Literature DB >> 25010737

Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.

Aref Najafi1, Saskia Schlossarek, Elza D van Deel, Nikki van den Heuvel, Ahmet Güçlü, Max Goebel, Diederik W D Kuster, Lucie Carrier, Jolanda van der Velden.   

Abstract

Hypertrophic cardiomyopathy (HCM), the most common genetic cardiac disorder, is frequently caused by mutations in MYBPC3, encoding cardiac myosin-binding protein C (cMyBP-C). Moreover, HCM is the leading cause of sudden cardiac death (SCD) in young athletes. Interestingly, SCD is more likely to occur in male than in female athletes. However, the pathophysiological mechanisms leading to sex-specific differences are poorly understood. Therefore, we studied the effect of sex and exercise on functional properties of the heart and sarcomeres in mice carrying a MYBPC3 point mutation (G > A transition in exon 6) associated with human HCM. Echocardiography followed by isometric force measurements in left ventricular (LV) membrane-permeabilized cardiomyocytes was performed in wild-type (WT) and heterozygous (HET) knock-in mice of both sex (N = 5 per group) in sedentary mice and mice that underwent an 8-week voluntary wheel-running exercise protocol. Isometric force measurements in single cardiomyocytes revealed a lower maximal force generation (F max) of the sarcomeres in male sedentary HET (13.0 ± 1.1 kN/m(2)) compared to corresponding WT (18.4 ± 1.8 kN/m(2)) male mice. Exercise induced a higher F max in HET male mice, while it did not affect HET females. Interestingly, a low cardiac troponin I bisphosphorylation, increased myofilament Ca(2+)-sensitivity, and LV hypertrophy were particularly observed in exercised HET females. In conclusion, in sedentary animals, contractile differences are seen between male and female HET mice. Male and female HET hearts adapted differently to a voluntary exercise protocol, indicating that physiological stimuli elicit a sexually dimorphic cardiac response in heterozygous MYBPC3-targeted knock-in mice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25010737     DOI: 10.1007/s00424-014-1570-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  64 in total

1.  Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.

Authors:  Tilmann Schober; Sabine Huke; Raghav Venkataraman; Oleksiy Gryshchenko; Dmytro Kryshtal; Hyun Seok Hwang; Franz J Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2012-05-29       Impact factor: 17.367

2.  Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.

Authors:  Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 5.  Current perspectives in diastolic dysfunction and diastolic heart failure.

Authors:  Adelino F Leite-Moreira
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

6.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

7.  Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.

Authors:  Alexander H Maass; Kaori Ikeda; Silke Oberdorf-Maass; Sebastian K G Maier; Leslie A Leinwand
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

8.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

9.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

Review 10.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Ray E Hershberger; Jason Cowan; Ana Morales; Jill D Siegfried
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

View more
  13 in total

1.  Sex Differences in Metabolic Cardiomyopathy.

Authors:  Elizabeth Murphy; Georgios Amanakis; Natasha Fillmore; Randi J Parks; Junhui Sun
Journal:  Cardiovasc Res       Date:  2017-02-01       Impact factor: 10.787

2.  Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.

Authors:  Frederik Flenner; Birgit Geertz; Silke Reischmann-Düsener; Florian Weinberger; Thomas Eschenhagen; Lucie Carrier; Felix W Friedrich
Journal:  J Physiol       Date:  2017-02-07       Impact factor: 5.182

3.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

4.  Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

Authors:  David Barefield; Mohit Kumar; Joshua Gorham; Jonathan G Seidman; Christine E Seidman; Pieter P de Tombe; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2014-11-25       Impact factor: 5.000

5.  Beneficial Effects of Cardiomyopathy-Associated Genetic Variants on Physical Performance: A Hypothesis-Generating Scoping Review.

Authors:  Sjoerd M Verwijs; Yigal M Pinto; Diederik W D Kuster; Jolanda van der Velden; Jacqueline Limpens; Juliette C van Hattum; Saskia N van der Crabben; Ronald H Lekanne Deprez; Arthur A M Wilde; Harald T Jørstad
Journal:  Cardiology       Date:  2021-10-27       Impact factor: 1.869

6.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 7.  The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease.

Authors:  Christa L Blenck; Pamela A Harvey; Jane F Reckelhoff; Leslie A Leinwand
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

8.  Epigallocatechin-3-Gallate Accelerates Relaxation and Ca2+ Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice.

Authors:  Felix W Friedrich; Frederik Flenner; Mahtab Nasib; Thomas Eschenhagen; Lucie Carrier
Journal:  Front Physiol       Date:  2016-12-05       Impact factor: 4.566

9.  Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy.

Authors:  Ilse A E Bollen; Marijke van der Meulen; Kyra de Goede; Diederik W D Kuster; Michiel Dalinghaus; Jolanda van der Velden
Journal:  Front Physiol       Date:  2017-12-22       Impact factor: 4.566

Review 10.  Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

Authors:  Gherardo Finocchiaro; Emma Magavern; Gianfranco Sinagra; Euan Ashley; Michael Papadakis; Maite Tome-Esteban; Sanjay Sharma; Iacopo Olivotto
Journal:  J Am Heart Assoc       Date:  2017-12-13       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.